FSHR and cancer: Published evidence supports ectopic and functional expression of FSHR1 in the angiogenic vasculature associated with several types of cancer (5, 8–14) and with various inflammatory diseases including benign prostatic hyperplasia (5), endometriosis (15, 16), and human atherosclerotic plaques (17).